Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Murray Ducharme"'
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 18, Iss 5 (2015)
Purpose: Clinical studies have suggested that proton pump inhibitors may decrease levothyroxine absorption and an in vitro study suggested that the effect of pH on dissolution may differ with formulation. To determine the impact of formulation on the
Externí odkaz:
https://doaj.org/article/8dd88cfd3a754744946607c674c6eae4
Autor:
Murray, Ducharme, Claudia, Scarsi, Elisa, Bettazzi, Giuseppe, Mautone, Yvette, Lewis, Francesco S, Celi
Publikováno v:
Thyroid. 32:897-904
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2172fbe4491c4ea43b4d961c0c43fb
https://doi.org/10.1089/thy.2021.0604
https://doi.org/10.1089/thy.2021.0604
Autor:
Kevin W Garey, Martin Kankam, Julie Mercier, Corinne Seng Yue, Murray Ducharme, Anne J Gonzales-Luna, M Jahangir Alam, Khurshida Begum, Michael Silverman
Publikováno v:
Open Forum Infectious Diseases
Background ACX-362E, a novel DNA polIIIC inhibitor, is a narrow-spectrum antibacterial selectively active against certain Gram-positive bacteria, including Clostridioides difficile (MIC90 = 4 µg/mL). The objectives of this phase I study was to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14797a1f0b2b919751c60ed5300cb28
https://doi.org/10.1093/ofid/ofz415.2490
https://doi.org/10.1093/ofid/ofz415.2490
Autor:
Jennifer B. Dressman, Paul Fackler, Leon Shargel, Terry Hyslop, Saji Thomas, Henning Blume, Yu Chung Tsang, Murray Ducharme, Mei-Ling Chen, Lorelei Lutter, Dennis Bashaw, Lawrence X. Yu, Masood Bhatti, José A.G. Morais, Eric Ormsby, Vinod P. Shah, Raja Velagapudi, Daan J.A. Crommelin
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Regulatory approaches for evaluating therapeutic equivalence of multisource (or generic) drug products vary among different countries and/or regions. Harmonization of these approaches may decrease the number of in vivo bioequivalence studies and avoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e262b8bf91c60b433e0fb7b67de9616b
https://pubmed.ncbi.nlm.nih.gov/21946259
https://pubmed.ncbi.nlm.nih.gov/21946259
Autor:
Mitchell A, Garrison, Lisa A, Hammond, Charles E, Geyer, Garry, Schwartz, Anthony W, Tolcher, Leslie, Smetzer, Jose A, Figueroa, Murray, Ducharme, John, Coyle, Chris H, Takimoto, Robert L, De Jager, Eric K, Rowinsky
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(7)
The purpose of this study was to assess the feasibility of administering exatecan, a water-soluble, potent camptothecin analogue, as a protracted 21-day continuous i.v. infusion (CIVI). The study also sought to determine the maximum tolerated dose (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2deaf4ebf044945fb7b94b8c12f3a06
https://pubmed.ncbi.nlm.nih.gov/12855627
https://pubmed.ncbi.nlm.nih.gov/12855627